Spdr S&P Biotech Etf

Business & Finance

Investors see a biotech comeback in 2024 as rates fall, deal-making picks up. Stocks to watch

[ad_1] Many biotech stocks struggled in 2023 despite a robust year for U.S. drug approvals. As these new therapies begin

Read More
Business & Finance

Here are the big health sector themes to watch next year

[ad_1] An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. David

Read More